Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Sitafloxacin Intermediates 131981-91-4,Sitafloxacin Intermediates for Bacterial CAS 131981-91-4,Sitafloxacin Intermediates CAS 131981-91-4
Conbott Pharmtech Co.,Ltd. Sitafloxacin Intermediates 131981-91-4,Sitafloxacin Intermediates for Bacterial CAS 131981-91-4,Sitafloxacin Intermediates CAS 131981-91-4
Home > Products > Intermediates > Anti-Biotics Intermediate > Sitafloxacin Intermediates for Bacterial Infections CAS 131981-91-4
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Sitafloxacin Intermediates for Bacterial Infections CAS 131981-91-4

Share to:  
    Min. Order: 1 Gram

Basic Info

Model No.131981-91-4

BrandConbottpharm

Additional Info

PackagingAS Required

ProductivityCustomized

Place of OriginChina

Supply AbilityCommercial

CertificateDOCUMENT SUPPORT

Product Description

Sitafloxacin is a new-generation, broad-spectrum oral fluoroquinolone antibiotic which widely used for against bacterial infections. We provide an important Intermediates for Sitafloxacin which is called NA with CAS NO 131981-91-4. NA CAS 131981-91-4 is white powder that is famous for its high purity, safe formulation and reliable. We can offer this product range from gram to kilogram grade. We are capable of meeting bulk requirement in short time.


Thera. Category: Treatment of respiratory and urinary tract infections.

Cas No.: 131981-91-4

Synonym: (Z)-Ethyl 3-fluoroacrylate

Molecular Formula:

Molecular Weight:

Assay: ≥97.%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: Sitafloxacin hydrate (DU-6859a, Gracevit), a new-generation, broad-spectrum oral fluoroquinolone that is very active against many Gram-positive, Gram-negative and anaerobic clinical isolates, including strains resistant to other fluoroquinolones, was recently approved for the treatment of respiratory and urinary tract infections.

Product Categories : Intermediates > Anti-Biotics Intermediate

Product Images
  • Sitafloxacin Intermediates for Bacterial Infections CAS 131981-91-4
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2024 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?